Search Results for keywords:"Allergy and Asthma Statistical

The Securities and Exchange Commission has received a proposal from Nasdaq BX to change how they handle the Options Regulatory Fee (ORF) starting on January 1, 2025. The change will adjust how fees are collected from different kinds of option transactions to better match the costs of regulation. Specifically, the proposal distinguishes between local and away trades and sets different fees for these categories. Nasdaq BX aims to ensure that these fees do not exceed 88% of the actual regulatory costs, and plans to revert to the previous fee system by July 1, 2025, unless further changes are made.

The Bureau of Justice Statistics (BJS) of the Department of Justice is submitting a request to the Office of Management and Budget (OMB) to approve a survey about forensic crime laboratories. This survey, called the Census of Publicly Funded Forensic Crime Laboratories (CPFFCL), aims to collect data from state and local government agencies, specifically from 350 crime laboratories, on their staffing, budgets, and challenges. Public comments on the survey can be submitted until March 3, 2025, and participation in the survey is voluntary. The collected data will help provide insight into forensic crime laboratories and will be shared in published reports by the BJS.

The Securities and Exchange Commission (SEC) has approved a rule change proposed by BOX Exchange LLC that allows the trading of options on the iShares Bitcoin ETF. This decision follows a similar proposal approved for Nasdaq ISE. The rule, effective immediately, establishes new position and exercise limits for these options, set at 25,000 contracts. This move is intended to provide investors with a cost-effective method to gain exposure to Bitcoin through a familiar public securities market. Additionally, BOX Exchange updated its rules to reflect the current names of certain trust funds.

The U.S. Department of the Treasury has announced agreements for six social impact partnership projects under the Social Impact Partnerships to Pay for Results Act (SIPPRA), amounting to $46.9 million. These projects, located in cities like Boise, Jacksonville, and New York City, as well as counties in Delaware and South Carolina, aim to address various social challenges such as homelessness, healthcare costs, and early childhood development. Each project outlines specific outcome goals, including healthcare and housing improvements, and defines metrics to evaluate success, with savings estimated for federal, state, and local governments if targets are met. The interventions span various timelines, with detailed methodologies planned for assessing their impact.

The Securities and Exchange Commission (SEC) announced the fiscal year 2021 adjustments to transaction fee rates under Sections 31(b) and (c) of the Securities Exchange Act of 1934. These fee rates are applied based on the total dollar amount of sales of certain securities, either on a national securities exchange or through members of a national securities association. The new fee rate is set at $5.10 per million dollars starting February 25, 2021. This rate aims to cover the SEC’s annual budget of $1,926,162,000, as specified in the Consolidated Appropriations Act, 2021.

The Federal Communications Commission has issued a new rule that changes several unbundling and resale requirements for telecommunications services. The rule eliminates certain obligations that require incumbent local exchange carriers (LECs) to offer unbundled access to their network elements, such as loop and transport facilities, where there is sufficient evidence of competition. The rule also ends the Avoided-Cost Resale requirements, which previously allowed competitive carriers to resell services at discounted rates, except for 911/E911 databases and operations support systems used for remaining obligations. The decision aims to encourage the transition to next-generation networks and services by removing outdated regulations where competition now exists.

Nasdaq MRX, LLC has introduced a new approach for calculating the Options Regulatory Fee (ORF) starting January 1, 2025, which differentiates fees based on where trades occur. The revised system will exclude Market Makers from the ORF and categorize trades under different rates depending on whether they occur on MRX or other exchanges. This update aims to refine the collection of ORF to more precisely cover regulatory costs and ensure no overlap with fees charged by other exchanges. The new method will expire on July 1, 2025, after which the previous fee structure will resume.

The Pecan Promotion, Research, and Information Order was established to help boost the pecan industry in the United States. It introduces a system to collect assessments from producers and importers to fund marketing campaigns and research aimed at increasing demand for pecans. The rule sets up a governing Board to oversee these activities and requires a referendum after three years to decide on the continuation of the order. While most of the industry supports this program, there are concerns about the financial burden on producers due to existing marketing orders.

The U.S. Fish and Wildlife Service is proposing to update the classification of the West Indian manatee by distinguishing between its two subspecies, listing the Florida manatee as a threatened species and the Antillean manatee as an endangered species under the Endangered Species Act. This proposal involves removing the West Indian manatee from the list and replacing it with the two subspecies to provide them with distinct protections. The Florida manatee faces threats like habitat loss, watercraft collisions, and climate change, whereas the Antillean manatee is endangered by factors like poaching, low genetic diversity, and ineffective regulatory enforcement in some areas. Public comments are invited on this proposed rule until March 17, 2025.

The Centers for Medicare & Medicaid Services (CMS) issued a final rule to establish a Medicare Coverage of Innovative Technology (MCIT) pathway, which provides faster access to new, FDA-designated breakthrough medical devices for Medicare beneficiaries. The rule allows up to four years of national Medicare coverage starting from the date of FDA market authorization, helping to ensure beneficiaries have timely access to cutting-edge treatments. Additionally, the rule defines "reasonable and necessary" criteria for determining Medicare coverage to ensure clarity and consistency with commercial insurers' practices. The MCIT pathway aims to encourage innovation while maintaining patient safety and evidence-based coverage decisions.